RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Brief Description

The AUTUMN Study is for adults living with primary membranous nephropathy (PMN), a rare kidney condition that can cause swelling in your lower body, tiredness, changes in urine, and weight gain. This research is studying ALXN1920, a potential new treatment, to see if it can help protect kidneys and prevent PMN from getting worse. Researchers want to find out how safe the study drug is, how well it works in your body, and if it can help reduce protein in your urine compared to a placebo (an inactive treatment).

Estimated Enrollment

30

Estimated End Date

17-Jun-26

Trial is for people with

Adults diagnosed with primary membranous nephropathy (PMN) who are at higher risk for kidney disease progression and are still losing ...

Study Goal

To learn if ALXN1920 can help preserve kidney function and prevent disease progression in people with PMN by lowering protein in the ...

What is involved for the patient?

If you join the study, you will continue your usual PMN treatment and also receive either ALXN1920 or placebo as a weekly infusion ...

About the drug or intervention

ALXN1920 is an investigational medicine designed to help regulate the immune system and protect the kidneys from damage caused by PMN. ...

Find other locations for this trial:
Loma Linda, CA

I'm Interested in this Trial

"*" indicates required fields

Your name*
This field is hidden when viewing the form
Your contact information will be sent to a team at
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
Have you ever had a kidney transplant?*
Are you currently on dialysis?*
Did you have a biopsy to confirm your diagnosis?*
Are you currently on the transplant wait-list?*
This field is hidden when viewing the form
This field is hidden when viewing the form
Interested in CT
Disclaimer

By clicking the submit button, your information and results will be sent to the study coordinator. Submitting the form does not guarantee enrollment but helps determine potential eligibility and connects you with the study team. Please consult your healthcare provider before pursuing participation in any trial.

Frequently Asked Questions

Nephrotic Syndrome is not a disease itself, but rather a group of signs and symptoms that result from damage in the part of the kidney that filters blood (glomeruli).

Common symptoms include:

  • Foamy urine (called proteinuria) caused by protein “spilling” into the urine
  • Severe swelling in parts of the body, most noticeably around the eyes, hands, feet, and abdomen (called edema)
  • Weight gain due to a buildup of extra fluid
  • Fatigue
  • Loss of appetite
  • Low levels of protein in the blood (hypoalbuminemia)
  • Higher than normal fat and cholesterol levels in the blood (hyperlipidemia)

Nephrotic Syndrome can typically be diagnosed with a urine test.

Nephrotic Syndrome can be “primary” or “secondary” in nature.

Diseases that affect only the kidneys are called primary causes of Nephrotic Syndrome. Doctors often call these diseases “idiopathic,” which means that they arise from an unknown cause. Some of these diseases include:

  • Minimal Change Disease (MCD) – most common in children
  • Focal Segmental Glomerulosclerosis (FSGS)
  • Membranous Nephropathy (MN) – most common in adults
  • IgA Nephropathy (IgAN)

Secondary Nephrotic Syndrome is caused by an underlying, systemic condition like diabetes, lupus, HIV, and others.

Clinical studies are any studies that involve people. There are two main types: observational and interventional. In an observational trial, researchers track health outcomes over time in groups of participants to look for patterns that help us better understand a disease. In an interventional trial, participants receive specific interventions, which can include new treatments or behavorial changes (e.g., diet changes). To learn more about clinical research, please visit the NephCure website.

See other frequently asked questions